WELL Health and HEALWELL AI Expand Strategic Alliance Agreement to Develop an AI-Enhanced Clinical Trials Program to Accelerate Innovation and Improve Patient Outcomes
WELL Health and HEALWELL AI announce the expansion of their multi-year agreement that allows WELL and HEALWELL to launch and manage clinical trial sites at WELL Health clinic locations across Canada. Leveraging HEALWELL's Contract Research Organization (CRO) capabilities alongside WELL Health's network of clinics across Canada, positions the partnership as a formidable player in AI-driven clinical trials, and opens up new revenue streams.This partnership allows HEALWELL AI to offer an...
2024-10-29 3:15 AM EDT
HEALWELL AI Announces Strategic Investment and Commercialization Agreement with Abstractive Health to Advance Generative AI-Powered Clinical Documentation Solutions
HEALWELL AI completes a strategic investment in NY-based Abstractive Health, alongside lead investor Rho Capital Partners, to support the development of AI-driven clinical documentation technology.Concurrent with the investment, HEALWELL also entered into a commercial agreement with Abstractive Health that provides HEALWELL with exclusive distribution rights to the Canadian outpatient healthcare market.Abstractive Health's AI software leverages LLMs and other generative AI technology to...
2024-10-22 5:00 AM EDT
BioPharma Services Announces Expansion into Late-Stage Patient Trials and Integration with HEALWELL's Artificial Intelligence Platform Capabilities to Become a Full-Service Next Generation CRO
HEALWELL's subsidiary, BioPharma Services, is expanding into late-stage patient trials through the integration of Canadian Phase Onward, a dedicated clinical research site built within the framework of HEALWELL's Polyclinic Family and Specialty Medicine Facility.This strategic integration is a significant milestone, enhancing BioPharma's ability to manage clinical trials across all phases of drug development and making the business a full-service Contract Research Organization. The move also...
2024-09-19 3:15 AM EDT
HEALWELL AI's Pentavere Nominated for 2024 Prix Galien Award, a Prestigious Award, for Its Contributions in AI for Life Sciences and Announces Participation at Key Medical Conferences
Pentavere is nominated for a 2024 Prix Galien Award for its contributions in AI and data science benefiting the human condition. The award is offered by the Galien Foundation and considered the most prestigious of all honours in the life sciences and pharmaceutical industry which is regularly awarded to recipients who are believed to have had the greatest impact on human health. This is Pentavere AI's third Prix Galien nomination in 3 years for the Best Digital Health Startup category....
2024-09-05 3:15 AM EDT
WELL Health's OceanMD and HEALWELL's Intrahealth Announce Partnership to Expand Access to eReferral Healthcare Solutions
British Columbia and Toronto, Ontario--(Newsfile Corp. - August 22,...
2024-08-22 7:15 AM EDT
HEALWELL AI Reports Record Revenue and a Healthy Balance Sheet in Q2-2024
HEALWELL achieved record quarterly revenue from continuing operations of $5.44 million in Q2-2024, 205% higher than the $1.78 million generated in Q2-2023 and 19% higher than the $4.58 million generated in Q1-2024.HEALWELL also reported net income of $2.54 million as compared to a loss of $9.81 million in Q2 2023. This was primarily due to the successful removal and settling of a significant number of liabilities incurred in past years. Management maintains a positive outlook, with HEALWELL's...
2024-08-12 4:50 PM EDT
HEALWELL AI to Announce Fiscal Second Quarter 2024 Financial Results on August 12, 2024
Toronto, Ontario--(Newsfile Corp. - August 7, 2024) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), an AI and data science company focused on preventative care, is pleased to announce the Company will release its Fiscal Second Quarter 2024 financial results for the period ended June 30, 2024, on Monday, August 12, 2024. The Company will...
2024-08-07 4:15 PM EDT
HEALWELL's Intrahealth Announces Patient Management Contract with the New Zealand Department of Corrections
New Zealand Department of Corrections over a 7-year agreement to improve offender healthcare through the delivery of a new patient management system.Toronto, Ontario--(Newsfile Corp. - July 31, 2024) - HEALWELL AI Inc. (TSX: AIDX, OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare technology company focused on AI and data science for preventative care, is pleased to announce its subsidiary, Intrahealth, a leading technology solutions provider specializing in electronic health records,...
2024-07-31 3:15 AM EDT
Province of New Brunswick Launches New Patient Summary with HEALWELL AI's VeroSource Solutions
VeroSource, a subsidiary of HEALWELL, built the new Patient Summary feature that launched on the MyHealthNB mobile app in partnership with Canada Health Infoway and the Government of New Brunswick.The Patient Summary feature allows users to create a summary of their medical information including medications, immunizations, lab results and imaging reports, which can then be securely shared with healthcare professionals and care providers. By enabling the secure sharing of personal health...
2024-07-25 3:15 AM EDT
HEALWELL AI Provides Corporate Update on Capital Allocation Program and Value Creation Strategy
HEALWELL's current goal is to achieve run rate revenues approaching $100 million by the end of the year from today's current run rate of over $65 million. This goal is underpinned by a robust M&A pipeline where there are several advanced subjects including one signed LOI and helps the Company position itself to achieve profitability on an Adjusted EBITDA basis in 2025.HEALWELL's four acquisitions to date have positioned the company to unlock the power of health data with artificial...
2024-07-23 3:15 AM EDT
WELL Health Launches its AI-powered Co-pilot for Cardiologists powered by HEALWELL AI to Help Improve Detection of Cardiovascular Disease
WELL has launched its new AI-powered physician co-pilot to assist cardiologists in better identifying patients at high risk of cardiovascular disease ("CVD"). WELL is exclusively partnering with HEALWELL AI, a leader in AI enabled disease diagnosis, as an extension of the WELL AI Decision Support ("WAIDS") product offering.The co-pilot will be deployed into WELL Diagnostic Centres, Canada's largest cardiology and medical diagnostic group, providing support and assisting cardiologists in over...
2024-07-17 3:15 AM EDT
HEALWELL Provides Corporate Update Reflecting Strengthened Balance Sheet with $15.5 Million Reduction of Total Liabilities
HEALWELL is pleased to provide an update on its improved balance sheet with the reduction of approximately $15.5 million of liabilities in Q2-2024. HEALWELL has successfully settled certain payment obligations related to the legacy MCI Medical Clinics Inc. ("MCI Ontario") business, resulting in extinguishing $3.9 million in future liabilities including rent and operating costs, and $2.5 million of payments in arrears.In addition, HEALWELL has received forgiveness as expected for the loans...
2024-07-10 7:00 AM EDT
HEALWELL AI Announces Successful Closing of Two Strategic Acquisitions: VeroSource Solutions and BioPharma Services
HEALWELL has completed the previously announced acquisitions of both VeroSource Solutions Inc. and BioPharma Services Inc., which boosts HEALWELL's proforma annualized revenue run-rate to be greater than $65 million and significantly improves HEALWELL's profitability. Serving five different provincial health clients across Canada, VeroSource is an end-to-end, customizable, cloud-based data interoperability platform that enables patients, care providers and administrators to seamlessly access...
2024-07-02 3:15 AM EDT
HEALWELL AI Announces Strategic Investment in xAI to Accelerate Development of Healthcare Focused Large Language Models That Benefit from xAI Developer Ecosystem
HEALWELL completes USD $2,000,000 strategic investment into an xAI investment vehicle as part of its capital allocation strategy where it seeks to enhance and accelerate the development of its healthcare focused data science capabilities by partnering with world class platforms and seeking opportunities to integrate them with its own proprietary data and technology.HEALWELL has made this investment through Think 1st Principles ("T1P"), an investment fund founded by HEALWELL shareholder and...
2024-06-26 3:15 AM EDT
HEALWELL AI Announces Voting Results of 2024 Annual General Meeting of its Shareholders
Toronto, Ontario--(Newsfile Corp. - June 25, 2024) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare technology company focused on AI and data science for preventative care, is pleased to announce the voting results from its annual general meeting of the shareholders of the Company held on June 25, 2024 (the "Meeting"). Shareholders holding shares entitled to exercise approximately 77.61% of the votes attributable to all of HEALWELL's outstanding shares...
2024-06-25 4:45 PM EDT
HEALWELL AI's Pentavere Demonstrates Its DARWEN AI System Can Support Earlier Detection of Radiation Related Toxicities in Cancer Patients for Preventative Care
Pentavere collaborated with Princess Margaret Cancer Centre's Radiation Oncology Department to assess the feasibility and accuracy of DARWEN™ AI to find patients experiencing radiation related toxicities based on information retrieved from electronic health records.The data and results from this groundbreaking AI research collaboration have been accepted for presentation at the American Society for Radiation Oncology in Washington DC on September 29th and the Canadian Association of Radiation...
2024-06-24 3:00 AM EDT
HEALWELL AI to Acquire BioPharma, One of Canada's Largest CROs, to Expand and AI-Enable Clinical Research Offerings
HEALWELL has entered into an agreement to acquire BioPharma Services Inc., one of the largest full-service Contract Research Organizations ("CRO") headquartered in Canada. BioPharma is focused on bioequivalence and early-stage clinical trials, with over 2,200 clinical trials completed to date with approximately 250 pharma clients since inception.BioPharma is expected to generate between $35 to $40 Million of revenue in 2024 with approximately 5% EBITDA1 operating margins based on YTD...
2024-06-13 7:00 AM EDT
WELL Health Launches 'WELL AI Decision Support' Powered by HEALWELL AI; Empowering Healthcare Providers with Next Generation Decision Support Systems
WELL announces the launch of WELL AI Decision Support, to assist healthcare providers in improving early disease diagnosis and preventative health.WELL is exclusively partnering with HEALWELL AI, a leader in AI enabled disease diagnosis to power its solutions both in Canada and the US.WELL's goal is to make AI Enabled Decision Support a core offering to all physicians supported by its fully managed and SaaS platforms which collectively power more than 31,000 physicians and other care...
2023-10-18 8:00 AM EDT
HEALWELL AI Announces Closing of $8 Million Bought Deal Private Placement
Toronto, Ontario--(Newsfile Corp. - October 17, 2023) - HEALWELL AI Inc. (TSX: AIDX) ("HEALWELL" or the "Company") is pleased to announce that it has closed its previously announced "bought deal" private placement financing of 13,333,400 Class A subordinate voting shares of the Company (the "Shares") at a price of $0.60 per Share, for aggregate gross proceeds of $8,000,040 (the "Offering"). The Offering was conducted on a "bought deal" private placement basis by Eight Capital, as lead...
2023-10-17 9:15 AM EDT